Home/Stocks/DNTH

DNTH

USD

Dianthus Therapeutics Inc. Common Stock

$33.200-0.690 (-2.036%)

Real-time Price

Healthcare

Biotechnology

United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics

Company Fundamentals

Trading Stats

Market Metrics

Open

$33.890

High

$34.110

Low

$32.960

Volume

0.43M

Company Fundamentals

Market Cap

1.3B

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.69M

Exchange

NCM

Currency

USD

52-Week Range

Low $13.37Current $33.200High $40.16

Related News

Oct 29, 2025 · 07:30 PM

GlobeNewswire

Dianthus Therapeutics Highlights New Claseprubart Data Presented During 2025 AANEM Annual Meeting

Positive data from Phase 2 MaGic trial presented for claseprubart in generalized Myasthenia Gravis, including new open-label extension data further supporting potential for 300mg/2mL Q4W dosing Phase 3 gMG trial planned

Oct 14, 2025 · 01:07 PM

Analyst Upgrades

Truist Securities Initiates Coverage On Dianthus Therapeutics with Buy Rating, Announces Price Target of $56

Truist Securities analyst Danielle Brill initiates coverage on Dianthus Therapeutics with a Buy rating and announces Price Target of $56.

Related Stocks

ALEX

Alexander & Baldwin Inc. REIT Holding Company

NASDAQ

Real Estate Inv...

CURIW

CuriosityStream Inc. Warrant

NASDAQ

Movies/Entertai...

HCVIU

Hennessy Capital Investment Corp. VI Unit

NASDAQ

Blank Checks

CHSCP

CHS Inc. 8% Cumulative Redeemable Preferred Stock

NASDAQ

Farming/Seeds/M...

CCIX

Churchill Capital Corp IX Ordinary Shares

NASDAQ

Stay Updated

Set price alerts, get AI analysis updates and real-time market news.